NASDAQ:CADL | Free Cash Flow | Candel Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$18.04M$675,000.00-$18.71M
2025-12-31-$10.57M$409,000.00-$10.98M
2025-03-31-$8.62M$3,000.00-$8.62M-116.80%
2024-12-31-$5.81M$3,000.00-$5.82M
2024-03-31-$8.44M$7,000.00-$8.45M
2023-12-31-$7.42M$47,000.00-$7.47M
2023-03-31-$10.82M$138,000.00-$10.96M
2022-12-31-$6.89M$276,000.00-$7.16M
2022-03-31-$8.05M$171,000.00-$8.22M
2021-12-31-$5.24M$504,000.00-$5.74M-359.77%
2021-03-31-$5.63M$229,000.00-$5.86M
2020-12-31-$3.42M$453,000.00-$3.87M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$38.31M$587,000.00-$38.9M
2024-12-31-$27.02M$16,000.00-$27.04M
2023-12-31-$34.24M$457,000.00-$34.7M
2022-12-31-$31.42M$1.3M-$32.72M
2021-12-31-$22.22M$1.84M-$24.05M
2020-12-31-$9.07M$1.48M-$10.55M